Showing results (141-150 of 201) with videos related to

Sort By:
Pageof 21
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 1, 2012
Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassayLori J Sokoll, Daniel W Chan, George G Klee, et al.
Plos Genetics|April 18, 2013
Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesisJesse D Riordan, Vincent W Keng, Barbara R Tschida, et al.
Neuro-Oncology Advances|May 12, 2021
Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivoSara H Osum, Alexander W Coutts, Dylan J Duerre, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
Scientific Reports|December 15, 2016
Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcomaTracy A Marko, Ghaidan A Shamsan, Elizabeth N Edwards, et al.
Plos Genetics|October 3, 2006
Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemersAron M Geurts, Lara S Collier, Jennifer L Geurts, et al.
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Molecular Cancer Research : MCR|May 22, 2015
Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor SuppressorCasey Dorr, Callie Janik, Madison Weg, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell LymphomaEric P Rahrmann, Natalie K Wolf, George M Otto, et al.
Pageof 21